Technologies

Semisolid Extrusion

Semisolid extrusion printing converts semisolid material into chewable printlets. The chewable formulations can be printed in any shape, and with different flavors, drug combinations and doses. These formulations are specially designed for children and geriatric populations.

SLS Printing

SLS (or selective laser sintering) printing uses a laser to convert a powder material into solid parts. FabRx can incorporate drugs into the powder to produce drug-loaded printlets.

Fused Deposition Modeling (FDM)

Fused deposition modeling printers melt a feedstock of extruded polymer onto a build plate, to construct an object layer-by-layer. FabRx manufactures its own filaments, comprised of pharmaceutical-grade polymers, and can load these with drug to create sustained or delayed release tablets or devices.

SLA Printing

SLA (or stereolithography) printing uses a laser to convert liquid material in to solid parts. FabRx can incorporate drugs into the polymer network to produce drug-loaded printlets.

SLA Printing Medical Devices

SLA printing allows incorporation of drugs into the polymer network to produce drug-loaded medical devices adapted to the shape of each individual.

Copyright © 2018 FabRx Ltd

Website Design by Creative Brand Design